Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction

Circulation

Volumn 103, Issue 1, 2001, Pages 155-160

  Woodiwiss, A J ^a,d   Tsotetsi, O J ^a,b   Sprott, S ^a   Lancaster, E J ^b   Mela, T ^c   Chung, E S ^c   Meyer, T E ^c   Norton, G R ^a,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Collagen; Diastole; Mechanics; Remodeling; Systole

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ISOPRENALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HEART DILATATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEART WEIGHT; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RAT;

EID: 0035830367     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.1.155     Document Type: Article

References (26)

1. Empiric determination of the transition from concentric hypertrophy to congestive heart failure in essential hypertension
2. Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure
3. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats
4. Collagen remodeling and changes in LV function during the development and recovery from supraventricular tachycardia
5. Inadequate collagen tethers in dilated cardiomyopathy
6. Differential expression of tissue inhibitors of metalloproteinases in failing human heart
7. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: Relation to ventricular and myocyte function
8. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure
9. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat
10. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy: Role of metalloproteinases and pyridinoline cross-links
11. Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: Changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans
12. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial (SAVE)
13. Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat
14. Collagen remodeling of the pressure-overloaded, hypertrophied non human primate myocardium
15. Determination of hydroxyproline
16. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats
17. Myocardial stiffness is attributed to alterations in cross-linked rather than total collagen or phenotypes in spontaneously hypertensive rats
18. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
19. Pathological hypertrophy and cardiac interstitium
20. Catecholamine cardiotoxicity
21. Posttranslational events in collagen biosynthesis
22. The enzymatic and nonenzymatic cross linking of collagen and elastin
23. Activation of matrix metalloproteinases in the failing human heart: Breaking the tie that binds
24. Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy: Effects on left ventricular and myocyte structure and function
25. Renin-angiotensin system and myocardial fibrosis in hypertension: Regulation of the myocardial collagen matrix
26. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis